Article

Future AI Will Be Able to Predict Antibody-Drug Conjugate Response in Oncology

2024-08-05

Abstract excerpt

The medical research field has been tremendously galvanized to improve the prediction of therapy efficacy by the revolution in artificial intelligence (AI). An earnest desire to find better ways to predict the effectiveness of therapy with the use of AI has propelled the evolution of new models in which it can become more applicable in clinical settings such as breast cancer detection. However, in some instances,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21cbd1b2-b555-5733-9091-623f35210e59
DOI: 10.20944/preprints202408.0099.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Future AI Will Be Able to Predict Antibody-Drug Conjugate Response in OncologyDOI 10.20944/preprints202408.0099.v2Read

AI-based Cancer Models for Prediction of Antibody-Drug Conjugate (ADC) Response in OncologySemantic proximity Read

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read

AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial OutcomesSemantic proximity Read

AI-based predictive biomarker discovery via contrastive learning retrospectively improves clinical trial outcomeSemantic proximity Read

Endocrine Therapy Recommendation for Estrogen Receptor Positive (ER + ) Metastases Advanced Breast Cancer using Machine Learning AlgorithmsSemantic proximity Read

Artificial intelligence assists precision medicine in cancer treatmentSemantic proximity Read

Artificial Intelligence in Immune Checkpoint Inhibitor Research: A Bibliometric Analysis of the LandscapeSemantic proximity Read

Artificial Intelligence in Multiple Myeloma: From Diagnostics and Clinical Trials to Drug DiscoverySemantic proximity Read

Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challengesSemantic proximity Read

In silico Antibody-Peptide Epitope prediction for Personalized cancer therapySemantic proximity Read

Prognostic Risk Refinement using Artificial Intelligence in HR+/HER2- Early Breast Cancer: Implications for CDK4/6 Eligibility CriteriaSemantic proximity Read

From Categorical to Continuous: A Symbiotic Human-AI Approach to HER2 Scoring in the Antibody-Drug Conjugates EraSemantic proximity Read